Cargando…
Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
BACKGROUND: There have been no studies of the patterns of post-marketing withdrawals of medicinal products to which adverse reactions have been attributed. We identified medicinal products that were withdrawn because of adverse drug reactions, examined the evidence to support such withdrawals, and e...
Autores principales: | Onakpoya, Igho J., Heneghan, Carl J., Aronson, Jeffrey K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740994/ https://www.ncbi.nlm.nih.gov/pubmed/26843061 http://dx.doi.org/10.1186/s12916-016-0553-2 |
Ejemplares similares
-
Correction to: Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature
por: Onakpoya, Igho J., et al.
Publicado: (2019) -
Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review
por: Onakpoya, Igho J., et al.
Publicado: (2016) -
Delays in the post-marketing withdrawal of drugs to which deaths have been attributed: a systematic investigation and analysis
por: Onakpoya, Igho J, et al.
Publicado: (2015) -
Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature
por: Sartori, Daniele, et al.
Publicado: (2020) -
Signals of Adverse Drug Reactions Communicated by Pharmacovigilance Stakeholders: A Scoping Review of the Global Literature
por: Sartori, Daniele, et al.
Publicado: (2022)